Icecure Medical (NASDAQ:ICCM) will release its quarterly earnings report on Tuesday, 2024-11-26. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Icecure Medical to report an earnings per share (EPS) of $-0.07.
The market awaits Icecure Medical's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Historical Earnings Performance
The company's EPS beat by $0.01 in the last quarter, leading to a 0.98% drop in the share price on the following day.
Here's a look at Icecure Medical's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.08 | -0.07 | -0.07 |
| EPS Actual | -0.06 | -0.08 | -0.07 | -0.09 |
| Price Change % | -1.0% | -1.0% | 0.0% | -6.0% |
Market Performance of Icecure Medical's Stock
Shares of Icecure Medical were trading at $0.7122 as of November 22. Over the last 52-week period, shares are down 39.48%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Icecure Medical visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
